The full time cycle operation of traceability for Roche has started. Today, officially, an amount of products defined and identified univocally during the month of February initiated its sale process with traceability. The first product has been a Mabthera 500, which from now on can be traced until its consumption by the patient, who shall validate the product, initiating an operation model which shall constitute a study case at global level.
Our congratulations to Roche and FOBESA´s team for their efforts.